These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12652245)

  • 21. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Potter MJ; Szabo SM; Chan EY; Morris AH
    Am J Ophthalmol; 2002 Jan; 133(1):149-51. PubMed ID: 11755857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis.
    Baba T; Nagayama M; Ohtsuki H; Hirooka K; Shiraga F
    Jpn J Ophthalmol; 2008; 52(1):68-70. PubMed ID: 18369705
    [No Abstract]   [Full Text] [Related]  

  • 23. Idiopathic juxtafoveolar retinal telangiectasis and pigment epithelial hyperplasia: an optical coherence tomographic study.
    Trabucchi G; Brancato R; Pierro L; Introini U; Sannace C
    Arch Ophthalmol; 1999 Mar; 117(3):405-6. PubMed ID: 10088825
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia.
    Konstantinidis L; Mantel I; Zografos L; Ambresin A
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov; 247(11):1567-9. PubMed ID: 19727795
    [No Abstract]   [Full Text] [Related]  

  • 25. Resolution of foveal pseudocyst after intravitreal triamcinolone acetonide.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Oct; 83(5):619-20. PubMed ID: 16188005
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.
    De Lahitte GD; Cohen SY; Gaudric A
    Am J Ophthalmol; 2004 Nov; 138(5):892-4. PubMed ID: 15531343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Triamcinolone acetonide bevacizumab performance in treatment and idiopathic macular spider veins].
    Cerbulescu B; Taina AL; Dinita M; Malaeanu R; Radocea R; Carstocea B
    Oftalmologia; 2010; 54(1):101-9. PubMed ID: 20540378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.
    Snyers B; Verougstraete C; Postelmans L; Leys A; Hykin P
    Am J Ophthalmol; 2004 May; 137(5):812-9. PubMed ID: 15126144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic juxtafoveal retinal telangiectasis: case report and literature review.
    Sindt SJ; Oh K
    Optometry; 2001 Apr; 72(4):228-33. PubMed ID: 11338447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.
    Hirano Y; Yasukawa T; Usui Y; Nozaki M; Ogura Y
    Br J Ophthalmol; 2010 May; 94(5):600-5. PubMed ID: 19846412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra wide field angiography in the diagnosis of aneurysmal retinal telangiectasia: a case report.
    Bohórquez MC; Navarro R; Corcóstegui B
    Semin Ophthalmol; 2009; 24(1):15-8. PubMed ID: 19241286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.
    Jorge R; Costa RA; Calucci D; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):1045-8. PubMed ID: 17136357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macular infarction after inadvertent intracameral cefuroxime.
    Qureshi F; Clark D
    J Cataract Refract Surg; 2011 Jun; 37(6):1168-9. PubMed ID: 21596262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.
    Cohen SM; Cohen ML; El-Jabali F; Pautler SE
    Retina; 2007 Jan; 27(1):59-66. PubMed ID: 17218917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in intravitreal triamcinolone acetonide use.
    Sobrin L; D'Amico DJ
    Int Ophthalmol Clin; 2005; 45(4):133-41. PubMed ID: 16199972
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
    Windisch R; Kozousek V
    Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy.
    Bandello F; Pognuz DR; Pirracchio A; Polito A
    Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):1024-7. PubMed ID: 15064955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
    Jonas JB; Kreissig I; Degenring RF
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
    Ozdemir H; Karacorlu M; Karacorlu S
    Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):734-6. PubMed ID: 15756580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):526-7. PubMed ID: 16187987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.